Summary

Continuous Positive Airway Pressure Devices Market Growth & Trends

The global continuous positive airway pressure devices market size is anticipated to reach USD 2.62 billion by 2030, growing at a CAGR of 5.45% during the forecast period, according to a new report by Grand View Research, Inc. The growing incidence of Obstructive Sleep Apnea (OSA), rising supportive initiatives by private organizations and the government for Continuous Positive Airway Pressure (CPAP) devices, technological advancements, and growing adoption of CPAP devices in home care settings due to increase in prevalence for home-based healthcare solutions and remote monitoring capabilities is fueling the market growth.

Rapid advancements have been made in integrating CPAP devices with intelligent technology and the Internet of Things (IoT). Modern CPAP devices can now connect to smartphones, tablets, and cloud-based platforms, enabling real-time monitoring and data sharing between patients and healthcare providers. This connectivity allows for remote tracking of therapy progress, instant feedback on usage, and even remote adjustments to device settings by doctors, reducing the need for in-person visits and ensuring that treatment remains effective over time. Mobile apps and innovative features also provide reminders, tips, and troubleshooting guidance, improving compliance and user engagement.

The rising preference for home-based healthcare solutions and remote monitoring capabilities boosts market growth. As healthcare systems shift care delivery from hospitals to patients' homes, there is a growing interest in leveraging sleep apnea devices for home-based noninvasive ventilation therapy. CPAP devices offer a cost-effective and convenient alternative to traditional hospital-based care, allowing patients to receive respiratory support in their homes. Home care settings allow patients to use CPAP devices in a familiar environment, enhancing comfort and therapy adherence. This is particularly significant for individuals requiring long-term management of sleep apnea, as they can integrate the device into their daily routines without the stress of hospital visits.

Continuous Positive Airway Pressure Devices Market Report Highlights

• Based on connectivity, the connected CPAP device segment dominated the market and held the largest revenue share of over 68.00% in 2024. This is attributed to the growing integration of advanced technology in sleep apnea management, offering real-time monitoring and personalized care, thus improving compliance and effectiveness.

• Based on end use, the home care settings segment dominated the market and held the largest revenue share of over 59.00% in 2024. This is attributed to the rising prevalence of OSA and advancements in CPAP technology, which are driving the adoption of homecare CPAP therapy, offering cost-effective, comfortable, and convenient solutions for patients.

• North America held the largest market share of 42.29% in 2024, attributed to significant market players and widespread adoption of CPAP devices due to the high prevalence of OSA.

• Key players operating in the CPAP devices market include ResMed; Fisher & Paykel Healthcare Limited; Koninklijke Philips N.V.; React Health (3B Medical); Medical Depot, Inc.; dba Drive DeVilbiss Healthcare; Transcend Inc. (Somnetics International, Inc.); Wellell Inc. (Apex Medical); BMC.

• In September 2022, Transcend. Inc. launched Transcend Micro, the lightest and smallest portable CPAP device for OSA patients. It measures under four inches and weighs half a pound

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Connectivity
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.8.2. Volume Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of Obstructive Sleep Apnea (OSA)
3.2.1.2. Technological advancements
3.2.1.3. Supportive initiatives by government and private organizations for CPAP devices
3.2.2. Market Restraint Analysis
3.2.2.1. Product recalls & failure
3.2.2.2. Complex regulatory framework pertaining to CPAP devices
3.2.3. Market Opportunity Analysis
3.2.3.1. Growing adoption of CPAP devices in home care settings
3.2.4. Pricing Analysis of CPAP Devices
3.2.5. Disease Demographics
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Connectivity Business Analysis
4.1. Connectivity Market Share, 2024 & 2030
4.2. Connectivity Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Connectivity, 2018 to 2030 (USD Million) (000`Units) (000’ Units)
4.4. Connected
4.4.1. Connected market, 2018 - 2030 (USD Million) (000`Units) (000’ Units)
4.4.2. Bluetooth-Connected CPAP
4.4.2.1. Bluetooth-connected CPAP market, 2018 - 2030 (USD Million) (000`Units) (000’ Units)
4.4.3. Wi-Fi & Cellular Connected CPAP
4.4.3.1. Wi-Fi & cellular connected CPAP market, 2018 - 2030 (USD Million) (000`Units) (000’ Units)
4.4.4. Hybrid-Connected
4.4.4.1. Hybrid-connected CPAP market, 2018 - 2030 (USD Million) (000`Units) (000’ Units)
4.5. Non-Connected
4.5.1. Non-connected market, 2018 - 2030 (USD Million) (000`Units) (000’ Units)
Chapter 5. End Use Business Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million) (000`Units)
5.4. Home Care Settings
5.4.1. Home care settings market, 2018 - 2030 (USD Million) (000`Units)
5.5. Hospitals & Clinics
5.5.1. Hospitals & clinics market, 2018 - 2030 (USD Million) (000`Units)
5.6. Others
5.6.1. Others market, 2018 - 2030 (USD Million) (000`Units)
Chapter 6. Regional Estimates & Trend Analysis by Connectivity, and End Use
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.4.2. U.S.
6.4.2.1. Key country dynamic
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.4.3. Canada
6.4.3.1. Key country dynamic
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.4.4. Mexico
6.4.4.1. Key country dynamic
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5. Europe
6.5.1. Europe Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5.2. UK
6.5.2.1. Key country dynamic
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5.3. Germany
6.5.3.1. Key country dynamic
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5.4. France
6.5.4.1. Key country dynamic
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5.5. Italy
6.5.5.1. Key country dynamic
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5.6. Spain
6.5.6.1. Key country dynamic
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5.7. Norway
6.5.7.1. Key country dynamic
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Norway Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5.8. Denmark
6.5.8.1. Key country dynamic
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Denmark Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.5.9. Sweden
6.5.9.1. Key country dynamic
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Sweden Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.6. Asia Pacific
6.6.1. Asia Pacific Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.6.2. Japan
6.6.2.1. Key country dynamic
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.6.3. China
6.6.3.1. Key country dynamic
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.6.4. India
6.6.4.1. Key country dynamic
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.6.5. South Korea
6.6.5.1. Key country dynamic
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. South Korea Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.6.6. Australia
6.6.6.1. Key country dynamic
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. Australia Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.6.7. Thailand
6.6.7.1. Key country dynamic
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. Thailand Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.7. Latin America
6.7.1. Latin America Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.7.2. Brazil
6.7.2.1. Key country dynamic
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.7.3. Argentina
6.7.3.1. Key country dynamic
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.8. MEA
6.8.1. MEA Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.8.2. South Africa
6.8.2.1. Key country dynamic
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamic
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.8.4. UAE
6.8.4.1. Key country dynamic
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
6.8.5. Kuwait
6.8.5.1. Key country dynamic
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2018 - 2030 (USD Million) (000`Units)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position/Share Analysis, 2024
7.3. Company Categorization
7.4. Exit Strategies of Existing Market Players and Their Impact on Market Competitors
7.5. Company Profiles/Listing
7.5.1. ResMed
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Koninklijke Philips N.V.
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Fisher & Paykel Healthcare Limited
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Medical Depot, Inc. dba Drive DeVilbiss Healthcare
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. React Health (3B Medical)
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Transcend Inc. (Somnetics International, Inc.)
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Wellell Inc. (Apex Medical)
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. BMC
7.5.8.1. Overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives